Sponsors
Gilead | Kite
Kite, a Gilead Company, is a global biopharmaceutical company based in Santa Monica, California, focused on achieving cures with cell therapy. As the global cell therapy leader, Kite has treated more patients with CAR T-cell therapy than any other company. Kite has the largest in-house cell therapy manufacturing network in the world, spanning process development, vector manufacturing, clinical trial supply and commercial product manufacturing.
AbbVie
At AbbVie, we are committed to advancing patient-centred innovations in Haematology that improve the lives of people living with blood cancers. Guided by our dedication to scientific discovery and compassion, we strive to redefine standards of care and enable better outcomes for patients in need. Today, our oncology portfolio comprises approved and investigational treatments for a wide range of both blood cancers and solid tumours. We are evaluating investigational medicines in multiple clinical trials across some of the world’s most widespread and debilitating cancers. As we work to have a remarkable impact on people’s lives, we are committed to exploring solutions to help patients obtain access to our cancer medicines.
For more information about AbbVie, please visit us at www.abbvie.com.au. Follow @abbvie on LinkedIn, Facebook, Instagram, X and YouTube.
Pfizer
One way or another, cancer touches all our lives. Which is why nothing is more personal, or more urgent, than our goal to find cures for cancer and to deliver on our purpose: breakthroughs that change patients’ lives.
Specialised Therapeutics
With the highest professional and ethical standards, we commercialise therapies and technologies that uniquely fulfil the unmet medical needs of our community across Australia, New Zealand, and South East Asia. Proudly Australian-owned, our haematology portfolio includes MINJUVI® (tafasitamab) for relapsed/refractory follicular lymphoma and NIKTIMVO™ (axatilimab) for chronic graft-versus-host disease.
Therakos Australia
Therakos Australia Pty Ltd specialises in photopheresis technology, and the company has been providing ECP (Extracorporeal Photopheresis) treatment for over 35 years.
The THERAKOS® CELLEX® Photopheresis System is the world’s only fully integrated and validated ECP system and is used by over 300 treatment centres in over 30 countries worldwide.
Beyond the THERAKOS® CELLEX® Photopheresis System, Therakos Healthcare Limited offers a comprehensive range of support services to help enable healthcare professionals (HCPs) to deliver ECP immunomodulation to patients.
Please see UVADEX Product Information and Important Safety Information for the ECP procedure at www.therakos.com.au.
Jazz Pharmaceuticals
Jazz Pharmaceuticals is a global Biopharmaceutical Company whose purpose is to transform the lives of patients and their families through innovation. We have a diverse portfolio of marketed medicines and novel product candidates, from early- to late-stage development, in Neuroscience and Haematology/Oncology.
Lilly
Lilly is a medicine company turning science into healing to make life better for people around the world. We’ve been pioneering life-changing discoveries for 150 years, and today our medicines help tens of millions of people across the globe.
Roche
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. Recognised as the world’s largest biotech company, Roche delivers truly differentiated medicines across oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system, committed to doing now what patients need next.
